Have a personal or library account? Click to login
Nicotine and Inflammatory Disease in Humans: A Systematic Review Cover

Nicotine and Inflammatory Disease in Humans: A Systematic Review

Open Access
|Apr 2022

References

  1. Vittecoq, O., T. Lequerré, V. Goëb, X. Le Loët, T.A. Abdesselam, and N. Klemmer: Smoking and Inflammatory Diseases; Best Pract. Res. Clin. Rheumatol. 22 (2008) 923–935. DOI: 10.1016/j.berh.2008.09.011
  2. Gomes, J.O., A. Watad, and Y. Shoenfeld: Nicotine and Autoimmunity: The Lotus’ Flower in Tobacco; Pharmacol. Res. 128 (2018) 101–109. DOI: 10.1016/j.phrs.2017.10.005
  3. Van Westerloo, D.J., I.A. Giebelen, S. Florquin, M.J. Bruno, G.J. Larosa, L. Ulloa, K.J. Tracey, and T. van der Poll: The Vagus Nerve and Nicotinic Receptors Modulate Experimental Pancreatitis Severity in Mice; Gastroenterology 130 (2006) 1822–1830. DOI: 10.1053/j.gastro.2006.02.022
  4. Marrero, M.B. and M. Bencherif: Convergence of Alpha 7 Nicotinic Acetylcholine Receptor-Activated Pathways for Anti-Apoptosis and Anti-Inflammation: Central Role for JAK2 Activation of STAT3 and NF-κB; Brain Res. 1256 (2009) 1–7. DOI: 10.1016/j.brainres.2008.11.053
  5. Nizri, E., M. Irony-Tur-Sinai, O. Lory, A. Orr-Urtreger, E. Lavi, and T. Brenner: Activation of the Cholinergic Anti-Inflammatory System by Nicotine Attenuates Neuroinflammation via Suppression of Th1 and Th17 Responses; J. Immunol. 183 (2009) 6681–6688. DOI: 10.4049/jimmunol.0902212
  6. Benowitz, N.L. and A.D. Burbank: Cardiovascular Toxicity of Nicotine: Implications for Electronic Cigarette Use; Trends Cardiovasc. Med. 26 (2016) 515–523. DOI: 10.1016/j.tcm.2016.03.001
  7. Filippini, P., A. Ceseario, M. Fini, F. Locatelli, and S. Rutella: The Yin and Yang of Non-Neuronal α7-Nicotinic Receptors in Inflammation and Autoimmunity; Curr. Drug Targets 13 (2012) 644–655. DOI: 10.2174/138945012800399008
  8. Fu, X., T. Zong, P. Yang, L. Li, S. Wang, Z. Wang, M. Li, X. Li, Y. Zou, Y. Zhang, L.H.H. Aung, Y. Yang, and T. Yu: Nicotine: Regulatory Roles and Mechanisms in Atherosclerosis Progression; Food. Chem. Toxicol. 151 (2021) 112154. DOI: 10.1016/j.fct.2021.112154
  9. Haass, M. and W. Kübler: Nicotine and Sympathetic Neurotransmission; Cardiovasc. Drugs Ther. 10 (1997) 657–665. DOI: 10.1007/BF00053022
  10. Dutta, P., G. Courties, Y. Wei, F. Leuschner, R. Gorbatov, C.S. Robbins, Y. Iwamoto, B. Thompson, A.L. Carlson, T. Heidt, M.D. Majmudar, F. Lasitschka, M. Etzrodt, P. Waterman, M.T. Waring, A.T. Chicoine, A.M. van der Laan, H.W.M. Niessen, J.J. Piek, B.B. Rubin, J. Butany, J.R. Stone, H.A. Katus, S.A Murphy, D.A. Morrow, M.S. Sabatine, C. Vinegoni, M.A. Moskowitz, M.J. Pittet, P. Libby, C.P. Lin, F.K. Swirski, R. Weissleder, and M. Nahrendorf: Myocardial Infarction Accelerates Atherosclerosis; Nature 487 (2012) 325–329. DOI: 10.1038/nature11260
  11. Page, M.J., J.E. McKenzie, P.M. Bossuyt, I. Boutron, T.C. Hoffman, C.D. Mulrow, L. Shamseer, J.M. Tetzlaff, E.A. Akl, S.E. Brennan, R. Chou, J. Glanville, J.M. Grimshaw, A. Hróbjartsson, M.M. Lalu, T. Li, E.W. Loder, E. Mayo-Wilson, S. McDonald, L.A. McGuiness, L.A. Stewart, J. Thomas, A.C. Tricco, V.A. Welch, P. Whiting, and D. Moher: The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews; Brit. Med. J. 372 (2021) n71. DOI: 10.1136/bmj.n71
  12. Matthews, A.M., R. Fu, T. Dana, and R. Chou: Intranasal or Transdermal Nicotine for the Treatment of Postoperative Pain; Cochrane Database Syst. Rev. (2016) CD009634. DOI: 10.1002/14651858.CD009634.pub2
  13. Ingram, J.R., J. Rhodes, B.K. Evans, and G.A.O. Thomas: Nicotine Enemas for Active Crohn’s Colitis: An Open Pilot Study; Gastroenterol. Res. Pract. (2008) 237185. DOI: 10.1155/2008/237185
  14. Carlens, C., M.-P. Hergens, J. Grunewald, A. Ekbom, A. Eklund, C.O. Höglund, and J. Askling: Smoking, Use of Moist Snuff, and Risk of Chronic Inflammatory Diseases; Am. J. Respir. Crit. Care Med. 181 (2010) 1217–1222. DOI: 10.1164/rccm.200909-1338OC
  15. Birtwistle, J.: The Role of Cigarettes and Nicotine in the Onset and Treatment of Ulcerative Colitis; Postgrad. Med. J. 72 (1996) 714–718. DOI: 10.1136/pgmj.72.854.714
  16. Slyk, M.P. and L.A. Frazee: Nicotine: Does it Have a Role in the Treatment of Ulcerative Colitis?; Am. J. Ther. 4 (1997) 141–148.
  17. Guslandi, M. and A. Tittobello: Pilot Trial of Nicotine Patches as an Alternative to Corticosteroids in Ulcerative Colitis; J. Gastroenterol. 31 (1996) 627–629. DOI: 10.1007/bf02355071
  18. Guslandi, M. and A. Tittobello: Outcome of Ulcerative Colitis after Treatment with Transdermal Nicotine; Eur. J. Gastroenterol. Hepatol. 10 (1998) 513–515. DOI: 10.1097/00042737-199806000-00014
  19. Louvet, B., M.P. Buisine, P. Desreumaux, W.J. Tremaine, J.P. Aubert, N. Porchet, M. Capron, A. Cortot, J.F. Colombel, and W.J. Sandborn: Transdermal Nicotine Increases Mucosal IL-8 Expression but Has No Effect on Mucin Gene Expression in Ulcerative Colitis; Inflamm. Bowel Dis. 5 (1999) 174–181. DOI: 10.1097/00054725-199908000-00005
  20. Van Dijk, A.P., M.A. Meijssen, A.J. Brouwer, W.C. Hop, J.D. van Bergeijk, C. Feyerabend, J.H. Wilson, and F.J. Zijlstra: Transdermal Nicotine Inhibits Interleukin 2 Synthesis by Mononuclear Cells Derived from Healthy Volunteers; Eur. J. Clin. Invest. 28 (1998) 664–671. DOI: 10.1046/j.1365-2362.1998.00344.x
  21. Green, J.T., B.K. Evans, J. Rhodes, G.A. Thomas, C. Ranshaw, C. Feyerbend, and M.A. Russell: An Oral Formulation of Nicotine for Release and Absorption in the Colon: Its Development and Pharmacokinetics; Br. J. Clin. Pharmacol. 48 (1999) 485–493. DOI: 10.1046/j.1365-2125.1999.00057.x
  22. Ingram, J.R., J. Rhodes, B.K. Evans, and G.A.O. Thomas: Preliminary Observations of Oral Nicotine Therapy for Inflammatory Bowel Disease: An Open-label, Phase I–II Study of Tolerance; Inflamm. Bowel Dis. 11 (2005) 1092–1096. DOI: 10.1002/ibd.3780111209
  23. Coulie, B., M. Camilleri, A.E. Bharucha, W.J. Sandborn, and D. Burton: Colonic Motility in Chronic Ulcerative Proctosigmoiditis and the Effects of Nicotine on Colonic Motility in Patients and Healthy Subjects; Aliment. Pharmacol. Ther. 15 (2001) 653–663. DOI: 10.1046/j.1365-2036.2001.00959.x
  24. McGrath, J., J.W.D. McDonald, and J.K. Macdonald: Transdermal Nicotine for Induction of Remission in Ulcerative Colitis; Cochrane Database Syst. Rev. (2004) CD004722. DOI: 10.1002/14651858.CD004722.pub2
  25. Pullan, R.D., J. Rhodes, S. Ganesh, V. Mani, J.S. Morris, G.T. Williams, R.G. Newcombe, M.A. Russell, C. Feyerabend, and G.A. Thomas: Transdermal Nicotine for Active Ulcerative Colitis; N. Engl. J. Med. 330 (1994) 811–815. DOI: 10.1056/NEJM199403243301202
  26. Thomas, G.A., J. Rhodes, K. Ragunath, V. Mani, G.T. Williams, R.G. Newcombe, M.A. Russell, and C. Feyerabend: Transdermal Nicotine Compared with Oral Prednisolone Therapy for Active Ulcerative Colitis; Eur. J. Gastroenterol. Hepatol. 8 (1996) 769–776.
  27. Sandborn, W.J., W.J. Tremaine, K.P. Offord, G.M. Lawson, B.T. Petersen, K.P. Batts, I.T. Croghan, L.C. Dale, D.R. Schroeder, and R.D. Hurt: Transdermal Nicotine for Mildly to Moderately Active Ulcerative Colitis. A Randomised, Double-Blind, Placebo-Controlled Trial; Ann. Intern. Med. 126 (1997) 364–371. DOI: 10.7326/0003-4819-126-5-199703010-00004
  28. Guslandi, M., R. Frego, E. Vale, and P.A. Testoni: Distal Ulcerative Colitis Refractory to Rectal Mesalamine: Role of Transdermal Nicotine Versus Oral Mesalamine; Can. J. Gastroenterol. 16 (2002) 293–296. DOI: 10.1155/2002/307218
  29. Lashner, B.A., S.B. Hanauer, and M.D. Silverstein: Testing Nicotine Gum for Ulcerative Colitis Patients. Experience with Single-Patient Trials; Dig. Dis. Sci. 35 (1990) 827–832. DOI: 10.1007/BF01536795
  30. Ingram, J.R., J. Rhodes, B.K. Evans, R.G. Newcombe, and G.A.O. Thomas: Comparative Study of Enema Retention and Preference in Ulcerative Colitis; Post-grad. Med. J. 81 (2005) 594–598. DOI: 10.1136/pgmj.2004.031690
  31. Ingram, J.R., G.A.O. Thomas, J. Rhodes, J.T. Green, N.D. Hawkes, J.L. Swift, E.D. Srivastava, B.K. Evans, G.T. Williams, R.G. Newcombe, E. Courtney, and S. Pillai: A Randomized Trial of Nicotine Enemas for Active Ulcerative Colitis; Clin. Gastroenterol. Hepatol. 3 (2005) 1107–1114. DOI: 10.1016/s1542-3565(05)00849-9
  32. Thomas, G.A., J. Rhodes, V. Mani, G.T. Williams, R.G. Newcombe, M.A. Russell, and C. Feyerabend: Transdermal Nicotine as Maintenance Therapy for Ulcerative Colitis; N. Engl. J. Med. 332 (1995) 988–992. DOI: 10.1056/NEJM199504133321503
  33. Richardson, C.E., J.M. Morgan, B. Jasani, J.T. Green, J. Rhodes, G.T. Williams, J. Lindstrom, S. Wonnacott, S. Peel, G.A.O. Thomas: Effect of Smoking and Transdermal Nicotine on Colonic Nicotinic Acetylcholine Receptors in Ulcerative Colitis; QJM 96 (2003) 57–65. DOI: 10.1093/qjmed/hcg007
  34. Sandborn, W.J., W.J. Tremaine, J.A. Leighton, G.M. Lawson, B.J. Zins, R.F. Compton, D.C. Mays, J.J. Lipsky, K.P. Batts, K.P. Offord, R.D. Hurt, and J. Green: Nicotine Tartrate Liquid Enemas for Mildly to Moderately Active Left-Sided Ulcerative Colitis Unresponsive to First-Line Therapy: A Pilot Study; Aliment. Pharmacol. Ther. 11 (1997) 663–671. DOI: 10.1046/j.1365-2036.1997.00208.x
  35. Nikfar, S., S. Ehteshami-Ashar, R. Rahimi, and M. Abdollahi: Systematic Review and Meta-Analysis of the Efficacy and Tolerability of Nicotine Preparations in Active Ulcerative Colitis; Clin. Ther. 32 (2010) 2304–2315. DOI: 10.1016/j.clinthera.2011.01.004
  36. Vleggar, F.P., H.R. van Buuren, G.P. van Berge Henegouwen, W.C. Hop, and K.J. van Erpecum: No Beneficial Effects of Transdermal Nicotine in Patients with Primary Sclerosing Cholangitis: Results of a Randomized Double-Blind Placebo-Controlled Cross-Over Study; Eur. J. Gastroenterol. Hepatol. 13 (2001) 171–175. DOI: 10.1097/00042737-200102000-00013
  37. Angulo, P., A.E. Bharucha, R.A. Jorgensen, C.K. DeSotel, W.J. Sandborn, N.F. Larusso, and K.D. Lindor: Oral Nicotine in Treatment of Primary Sclerosing Cholangitis: A Pilot Study; Dig. Dis. Sci. 44 (1999) 602–607. DOI: 10.1023/a:1026673811278
  38. Lambrichts, D.P.V., G.S.A. Boersema, B. Tas, Z. Wu, W.W. Vrijland, G.-J. Kleinrensink, J. Jeekel, J.F. Lange, and A.G. Menon: Nicotine Chewing Gum for the Prevention of Postoperative Ileus after Colorectal Surgery: A Multicenter, Double-Blind, Randomised, Controlled Pilot Study; Int. J. Colorectal Dis. 32 (2017) 1267–1275. DOI: 10.1007/s00384-017-2839-z
  39. Price, L.R. and J. Martinez: Cardiovascular, Carcinogenic and Reproductive Effects of Nicotine Exposure: A Narrative Review of the Scientific Literature; F1000 Res. 8 (2020) 1586. DOI: 10.12688/f1000research.20062.2
  40. Palmer, R.M., J.A. Stapleton, G. Sutherland, P.Y. Coward, R.F. Wilson, and D.A. Scott: Effect of Nicotine Replacement and Quitting Smoking on Circulating Adhesion Molecule Profiles (sICAM-1, sCD44v5, sCD44v6); Eur. J. Clin. Invest. 32 (2002) 852–857. DOI: 10.1046/j.1365-2362.2002.01067.x
  41. Mobarrez, F., L. Antoniewicz, L. Hedman, J.A. Bosson, and M. Lundbäck: Electronic Cigarettes Containing Nicotine Increase Endothelial and Platelet Derived Extracellular Vesicles in Healthy Volunteers; Atherosclerosis 301 (2020) 93–100. DOI: 10.1016/j.atherosclerosis.2020.02.010
  42. Mah, E., R. Pei, Y. Guo, C. Masterjohn, K.D. Ballard, B.A. Taylor, A.W. Taylor, M.G. Traber, J.S. Volek, and R.S. Bruno: Greater γ-Tocopherol Status During Acute Smoking Abstinence with Nicotine Replacement Therapy Improved Vascular Endothelial Function by Decreasing 8-iso-15(S)-Prostaglandin F2α; Exp. Biol. Med. (Maywood) 240 (2015) 527–533. DOI: 10.1177/1535370214556948
  43. Xue, C., Q.Z. Chen, L. Bian, Z.F. Yin, Z.J. Xu, A.L. Zhang, Y.S. Xie, H.L. Zhang, R. Du, and C.Q. Wang: Effects of Smoking Cessation with Nicotine Replacement Therapy on Vascular Endothelial Function, Arterial Stiffness, and Inflammation Response in Healthy Smokers; Angiology 70 (2019) 719–725. DOI: 10.1177/0003319719853458
  44. Antoniewicz, L., A. Brynedal, L. Hedman, M. Lundbäck, and J.A. Bosson: Acute Effects of Electronic Cigarette Inhalation on the Vasculature and the Conducting Airways; Cardiovasc. Toxicol. 19 (2019) 441–450. DOI: 10.1007/s12012-019-09516-x
  45. Antoniewicz, L., J.A. Bosson, J. Kuhl, S.M. Abdel-Halim, A. Kiessling, F. Mobarrez, and M. Lundbäck: Electronic Cigarettes Increase Endothelial Progenitor Cells in the Blood of Healthy Volunteers; Atherosclerosis 255 (2016) 179–185. DOI: 10.1016/j.atherosclerosis.2016.09.064
  46. Farsalinos, K.E. and R. Polosa: Endothelial Progenitor Cell Release Is Usually Considered a Beneficial Effect: Problems in Interpreting the Acute Effects of E-Cigarette Use; Atherosclerosis 258 (2017) 162–163. DOI: 10.1016/j.atherosclerosis.2016.12.016
  47. Antoniewicz, L., A. Kiessling, F. Mobarrez, and M. Lundbäck: Reply to: “Endothelial Progenitor Cell Release Is Usually Considered a Beneficial Effect: Problems in Interpreting the Acute Effects of E-Cigarette Use”; Atherosclerosis 258 (2017) 164–165. DOI: 10.1016/j.atherosclerosis.2017.01.019
  48. Mills, C.M., S.A. Hill, and R. Marks: Transdermal Nicotine Suppresses Cutaneous Inflammation; Arch. Dermatol. 133 (1997) 823–825. DOI: 10.1001/archderm.1997.03890430023004
  49. Yoshifuku, A., Y. Higashi, S. Matsushita, K. Kawai, and T. Kanekura: Transdermal Nicotine Patches for Eosinophilic Pustular Folliculitis; J. Dermatol. 40 (2013) 711–714. DOI: 10.1111/1346-8138.12211
  50. Sørensen, L.T.: Wound Healing and Infection in Surgery: The Pathophysiological Impact of Smoking, Smoking Cessation, and Nicotine Replacement Therapy: A Systematic Review; Ann. Surg. 255 (2012) 1069–1079. DOI: 10.1097/SLA.0b013e31824f632d
  51. Kaklamani, V.G., N. Markomichelakis, and P.G. Kaklamanis: Could Nicotine Be Beneficial for Behçet’s Disease?; Clin. Rheumatol. 21 (2002) 341–342. DOI: 10.1007/s100670200090
  52. Ciancio, G., M. Colina, R. La Corte, A. Lo Monaco, F. De Leonardis, F. Trotta, and M. Govoni: Nicotine-patch Therapy on Mucocutaneous Lesions of Behçet’s Disease: A Case Series; Rheumatology (Oxford) 49 (2010) 501–504. DOI: 10.1093/rheumatology/kep401
  53. Landim, F.S., J.R. Laureano Filho, J. Nascimento, and B.C. do Egito Vasconcelos: Effectiveness of Nicotine Patch for the Control of Pain, Oedema, and Trismus Following Third Molar Surgery: A Randomized Clinical Trial; Int. J. Oral Maxillofac. Surg. 49 (2020) 1508–1517. DOI: 10.1016/j.ijom.2019.08/013
  54. Wittebole, X., S. Hahm, S.M. Coyle, A. Kumar, S.E. Calvano, and S.F. Lowry: Nicotine Exposure Alters in Vivo Human Responses to Endotoxin; Clin. Exp. Immunol. 147 (2007) 28–34. DOI: 10.111/j.1365-2249.2006.03248.x
  55. Janum, S., S.T. Nielsen, M.U. Werner, J. Mehlsen, H. Kehlet, and K. Møller: Pain Perception in Healthy Volunteers: Effect of Repeated Exposure to Experimental Systemic Inflammation; Innate Immun. 22 (2016) 546–556. DOI: 10.1177/1753425916663638
  56. Hade, E.M., R.M. Smith, D.A. Culver, and E.D. Crouser: Design, Rationale, and Baseline Characteristics of a Pilot Randomized Clinical Trial of Nicotine Treatment for Pulmonary Sarcoidosis; Contemp. Clin. Trials Commun. 20 (2020) 100669. DOI: 10.1016/j.conctc.2020.100669
  57. Julian, M.W., G. Shao, L.S. Schlesinger, Q. Huang, D.G. Cosmar, N.Y. Bhatt, D.A. Culver, R.P. Baughman, K.L. Wood, and E.D. Crouser: Nicotine Treatment Improves Toll-Like Receptor 2 and Toll-Like Receptor 9 Responsiveness in Active Pulmonary Sarcoidosis; Chest 143 (2013) 461–470. DOI: 10.1378/chest.12-0383
  58. Crouser, E.D., R.M. Smith, D.A. Culver, M.W. Julian, K. Martin, J. Baran, C. Diaz, B.S. Erdal, and E.M. Hade: A Pilot Randomized Trial of Transdermal Nicotine for Pulmonary Sarcoidosis; Chest 160 (2021) 1340–1349. DOI: 10.1016/j.chest.2021.05.031
  59. Hedström, A.K., M. Bäärnhielm, T. Olsson, and L. Alfredsson: Tobacco Smoking, but Not Swedish Snuff Use, Increases the Risk of Multiple Sclerosis; Neurology 73 (2009) 696–701. DOI: 10.1212/WNL.0b013e3181b59c40
  60. Hedström, A.K., J. Hillert, T. Olsson, and L. Alfredsson: Nicotine Might Have a Protective Effect in the Etiology of Multiple Sclerosis; Mult. Scler. 19 (2013) 1009–1013. DOI: 10.1177/1352458512471879
  61. U.S. Department of Health and Human Services (DHHS): The Health Consequences of Smoking – 50 Years of Progress: A Report of the Surgeon General; DHHS, Atlanta, GA, USA, 2014. Available at https://www.ncbi.nlm.nih.gov/books/NBK179276/pdf/Bookshelf_NBK179276.pdf (accessed November 19, 2021).
Language: English
Page range: 10 - 24
Submitted on: Nov 23, 2021
Accepted on: Feb 23, 2022
Published on: Apr 16, 2022
Published by: Institut für Tabakforschung GmbH
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 Leonie Price, Keith Thompson, Javier Martinez, published by Institut für Tabakforschung GmbH
This work is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License.